Implementing A Diversity Plan: Operational Considerations For Your Clinical Trial

This presentation explores how to enhance diversity in clinical trials with expert insights on the FDA’s draft guidance for increasing enrollment from underrepresented populations.

Industry leaders, including former FDA senior official Isaac Rodriguez-Chavez, dive into the FDA’s Diversity Action Plans and practical strategies for integrating these plans into clinical trial operations, from small studies to large global trials.

Other topics include:

• The purpose and key goals of the FDA guidance.
• How to develop and implement diversity plans for various trial sizes.
• Solutions for overcoming site selection and recruitment challenges.
• Best practices for integrating diversity initiatives into existing frameworks.

Gain valuable insights to improve enrollment, meet regulatory expectations, and ensure your clinical trials reflect diverse populations. Don’t miss this opportunity to align your strategies with the FDA’s evolving diversity standards.